New breakthrough could help treat muscular dystrophy

August 13, 2012 By Raquel Maurier, University of Alberta
U of A medical researcher Toshifumi Yokota used a new drug cocktail to lessen the severity of Duchenne muscular dystrophy symptoms in lab models.

A researcher in the Faculty of Medicine & Dentistry at the University of Alberta improved Duchenne muscular dystrophy symptoms in non-human lab models, using a new drug cocktail. The drug combination targets the “hot spot” of the gene mutation, making the condition less severe.

Toshifumi Yokota, the study’s principal investigator, published his findings Aug. 6 in the peer-reviewed journal, Proceedings of the National Academy of Sciences. He is a researcher in the Department of Medical Genetics and holds two research chairs: The Friends of Garrett Cumming Research Chair, Canada; and the H.M. Toupin Neurological Science Chair.

Yokota has worked on this research for more than five years. He is now using the same on human cells with Duchenne muscular dystrophy and hopes to see similar results.

Duchenne muscular dystrophy, one of the most common genetic disorders, is caused by a lack of dystrophin, a muscle-supporting protein. In the lab, the drug cocktail improved normal functioning of the mutated gene that triggers the condition. The therapy allowed the lab models to produce 10 per cent to 15 per cent normal levels of dystrophin.

“With this drug cocktail, we were able to target the hot-spot mutated parts of the gene,” said Yokota. “The results were very good—better than we expected. The Duchenne muscular dystrophy condition was less severe.”

Yokota noted that about half of those living with Duchenne could potentially benefit from the drug cocktail, once further testing is conducted and clinical trials are completed.

He worked with colleagues in the United States and Japan on the findings.

Explore further: Researchers review muscular dystrophy therapies

Related Stories

Researchers review muscular dystrophy therapies

June 22, 2012
Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy in an article published ...

Recommended for you

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.